LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit
LivaNova appointed Stefano Folli as President of its Cardiopulmonary business unit, effective June 1, succeeding Franco Poletti who is retiring. Folli, formerly Executive Vice President at Philips, will oversee the nearly $800 million Cardiopulmonary segment, which includes the Essenz Perfusion System.
Key figures
- Cp business revenue
- $800 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.